DNO ASA is a Norway-based oil and gas exploration and production company. It is engaged in the acquisition, development and operation of oil and gas properties. The Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in the Kurdistan region of Iraq, Norway, the United Kingdom, Cote d’Ivoire, Netherlands and Yemen. Norway and the United Kingdom represent nearly 60 percent of the Company’s global production and about 45 percent of its global reserves, with the balance predominantly in the Kurdistan region of Iraq. The Company operates through its head office in Oslo, and a network of offices throughout the MENA region. Its subsidiaries include DNO Yemen AS, DNO UK Ltd, DNO Invest AS, DNO Tunisia AS, DNO Iraq AS, and DNO Mena AS.
Company Information
About this company
Key people
Bijan Mossavar-Rahmani
Executive Chairman of the Board
Erlend Wollan Einum
Chief Business Development Officer
Anita Marie Hjerkinn Aarnaes
Human Resource Director
Elin Karfjell
Director
Najmedin Meshkati
Director
Gunnar Hirsti
Deputy Chairman of the Board
Birgitte Wendelbo Johansen
Chief Financial Officer
Geir Arne Skau
Chief Human Resources and Corporate Services Officer
Erling Moen Synnes
Chief Information Officer
Tonje Pareli Gormley
General Counsel - Middle East
Christopher Thomas Hyde Spencer
Managing Director
Elisabeth Femsteinevik
General Manager - DNO North Sea
Sameh Marie Hjerkinn Hanna
General Manager, Kurdistan Region of Iraq
Click to see more
Key facts
- Shares in issue975.00m
- EPICDNO
- ISINNO0003921009
- LocationNorway
- SectorEnergy
- IndustryOil & Gas Operations
- Market capNOK 16.15bn
- Employees1,070
- ExchangeOslo Stock Exchange
- IndexOSL All-share Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.